ERK1/2-targeted Cancer therapies: Recent advances, potential drug resistance, and applicability analysis of emerging technologies

Authors:

Abstract
No abstract available
Funding Information
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen University
  • Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20240813161112017)

This publication has 83 references indexed in Scilit: